Cutting-edge science for healthcare

We are an important partner to the Slovenian healthcare system with our generic and biosimilar medicines.

Read key business and development news in our company and various activities that we support and co-create. You can also browse the news archives dating back to 1998, our photo library and visual identity. For additional information, you can write to us at

Press releases
16. 10. 2023

Prof. Zdenko Časar, PhD, Head of Early Stage Development at Lek, has been awarded the Puh Award for his outstanding work in the ...

4. 10. 2023

Sandoz, the global leader in generic and biosimilar medicines, today celebrates the start of share trading on the SIX Swiss Exchange as an independent company. 

20. 9. 2023

Yesterday,the Chamber of Commerce and Industry of Slovenia presented awards for the bestinnovations in the country. Atthe Innovation Day held at Brdo ...

12. 9. 2023

Between September 7 and 10, Lek, a Sandoz company, hosted ScienceBEAT, a world-class scientific and professional event aimed at promising natural sciences and business students ...


Lek d.d.
Verovškova 57, 1526 Ljubljana, Slovenia
T: +386 1 580 21 11
F: +386 1 568 35 17
VAT No.: SI87916452
Registration number: 1732811000
Nominal capital: 48.402.003,00 EUR

Video library